4731-87-7

Basic information

• Product Name: Diisoeugenol, dehydrodihydro-
• Synonyms: Diisoeugenol, dehydrodihydro-;4-(2,3-Dihydro-7-methoxy-3-methyl-5-propylbenzofuran-2-yl)-2-methoxyphenol;Dehydrodihydrodiisoeugenol
• CAS NO: 4731-87-7
• Molecular Formula: C₂₀H₂₄O₄
• Molecular Weight: 328.40216
• Mol File: 4731-87-7.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Diisoeugenol, dehydrodihydro-(CAS DataBase Reference)
• NIST Chemistry Reference: Diisoeugenol, dehydrodihydro-(4731-87-7)
• EPA Substance Registry System: Diisoeugenol, dehydrodihydro-(4731-87-7)

Safety Data

• Hazardous Substances Data: 4731-87-7(Hazardous Substances Data)

Upstream product

• 2680-81-1 2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-trans-3-methyl-5-(Z)-propenyl-benzofuran 

Downstream Products

• 121-34-6 3-methoxy-4-hydroxybenzoic acid 
• 121-33-5 vanillin 
• 95955-30-9 1-(3-Methoxy-4-acetoxy-phenyl)-2-(3-methoxy-2-acetoxy-5-propyl-phenyl)-propen-⁽¹⁾ 
• 19997-33-2 1-(3-Methoxy-4-acetoxy-phenyl)-2-(3-methoxy-2-acetoxy-5-propyl-phenyl)-propan 
• 22329-69-7 trans-2,4'-Diacetoxy-3,3'-dimethoxy-5-propyl-α-methyl-trans-stilben 
• 6711-43-9 1-(4-hydroxy-3-methoxy-phenyl)-2-(2-hydroxy-3-methoxy-5-propyl-phenyl)-propane 

Relevant articles and documents

USE OF DIHYDRODEHYDRODIISOEUGENOL AND PREPARATIONS COMPRISING DIHYDRODEHYDRODIISOEUGENOL

This invention relates to cosmetic and pharmaceutical preparations comprising (i) a diastereomer or a mixture of two or more diastereomers of the compound of formula (I) or (ii) a salt of a diastereomer or of a mixture of two or more diastereomers of the compound of formula (I) or (iii) a mixture of two or more salts of a diastereomer or of a mixture of two or more diastereomers of the compound of formula (I), a diastereomer, salt or a mixture as defined above as a drug for topical application and/or for the treatment of lipoatrophy; the non-therapeutic use of a diastereomer, salt or a mixture as defined above for the prevention, treatment or reduction of skin aging, especially skin wrinkles; the use of a diastereomer, salt or a mixture as defined above for the production of an orally administered non-pharmaceutical preparation.